Elevation of dopamine D2 receptors in schizophrenia is underestimated by radioactive raclopride.
Seeman
P
P
Niznik
H B
HB
Guan
H C
HC
D000818:Animals; D001921:Brain / Q000378:metabolism*; D002250:Carbon Radioisotopes / Q000378:metabolism*; D002421:Caudate Nucleus / Q000378:metabolism; D002531:Cerebellum / Q000378:metabolism; D003342:Corpus Striatum / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D018492:Dopamine Antagonists; D006801:Humans; D011699:Putamen / Q000378:metabolism; D020891:Raclopride; D011954:Receptors, Dopamine / Q000378:metabolism*; D012457:Salicylamides / Q000378:metabolism*; D012559:Schizophrenia / Q000175:diagnosis / Q000378:metabolism*; D013134:Spiperone / Q000378:metabolism; D014055:Tomography, Emission-Computed / Q000592:standards; D014316:Tritium
D002250:Carbon Radioisotopes; D018492:Dopamine Antagonists; D011954:Receptors, Dopamine; D012457:Salicylamides; D014316:Tritium; D020891:Raclopride; D013134:Spiperone; D004298:Dopamine